{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:41:23Z","timestamp":1789753283857,"version":"4.0.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":63,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08172-4","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T02:06:04Z","timestamp":1778637964000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["In-depth serum proteomics atlas of COVID-19 defines a Severity-Resistance Index from a four-protein panel for disease severity and prognosis"],"prefix":"10.1186","volume":"24","author":[{"given":"Liheng","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruilan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieming","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"8172_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijsu.2020.02.034","volume":"76","author":"C Sohrabi","year":"2020","unstructured":"Sohrabi C, Alsafi Z, O\u2019Neill N, Khan M, Kerwan A, Al-Jabir A, et al. World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020, Apr;76:71\u201376. https:\/\/doi.org\/10.1016\/j.ijsu.2020.02.034.","journal-title":"Int J Surg"},{"key":"8172_CR2","unstructured":"World Health Organization. COVID-19 - global situation [Internet]. [cited 2025 July 22]. Available from: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2025-DON572"},{"issue":"10332","key":"8172_CR3","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S0140-6736(22)00462-7","volume":"399","author":"T Nyberg","year":"2022","unstructured":"Nyberg T, Ferguson NM, Nash SG, Webster HH, Flaxman S, Andrews N, et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Lancet. 2022, Apr, 2;399(10332):1303\u201312. https:\/\/doi.org\/10.1016\/S0140-6736(22)00462-7.","journal-title":"Lancet"},{"issue":"3","key":"8172_CR4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41579-022-00841-7","volume":"21","author":"AM Carabelli","year":"2023","unstructured":"Carabelli AM, Peacock TP, Thorne LG, Harvey WT, Hughes J, de Silva TI, et al. SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nat Rev Microbiol. 2023;21(3):162\u201377. https:\/\/doi.org\/10.1038\/s41579-022-00841-7.","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"8172_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.idc.2022.11.001","volume":"37","author":"Y Abul","year":"2023","unstructured":"Abul Y, Leeder C, Gravenstein S. Epidemiology and clinical presentation of COVID-19 in older adults. Infect Dis Clin N Am. 2023, Mar;37(1):1\u201326. https:\/\/doi.org\/10.1016\/j.idc.2022.11.001.","journal-title":"Infect Dis Clin N Am"},{"issue":"1","key":"8172_CR6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.idc.2023.12.010","volume":"38","author":"R Cavallazzi","year":"2024","unstructured":"Cavallazzi R, Ramirez JA. Influenza and viral pneumonia. Infect Dis Clin N Am. 2024, Mar;38(1):183\u2013212. https:\/\/doi.org\/10.1016\/j.idc.2023.12.010.","journal-title":"Infect Dis Clin N Am"},{"issue":"1","key":"8172_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2020.05.032","volume":"182","author":"B Shen","year":"2020","unstructured":"Shen B, Yi X, Sun Y, Bi X, Du J, Zhang C, et al. Proteomic and metabolomic characterization of COVID-19 patient sera. Cell. 2020, July, 9;182(1):59\u201372.e15. https:\/\/doi.org\/10.1016\/j.cell.2020.05.032.","journal-title":"Cell"},{"issue":"2","key":"8172_CR8","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cmet.2020.06.016","volume":"32","author":"JW Song","year":"2020","unstructured":"Song JW, Lam SM, Fan X, Cao WJ, Wang SY, Tian H, et al. Omics-driven systems interrogation of metabolic dysregulation in COVID-19 pathogenesis. Cell Metab. 2020, Aug, 4;32(2):188\u2013202.e5. https:\/\/doi.org\/10.1016\/j.cmet.2020.06.016.","journal-title":"Cell Metab"},{"issue":"10229","key":"8172_CR9","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in wuhan, China: a retrospective cohort study. Lancet. 2020, Mar, 28;395(10229):1054\u201362. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3.","journal-title":"Lancet"},{"key":"8172_CR10","doi-asserted-by":"publisher","unstructured":"Poudel A, Poudel Y, Adhikari A, Aryal BB, Dangol D, Bajracharya T, et al. D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19. PLoS One. 2021, Aug, 26;16(8):e0256744. https:\/\/doi.org\/10.1371\/journal.pone.0256744.","DOI":"10.1371\/journal.pone.0256744"},{"key":"8172_CR11","doi-asserted-by":"publisher","first-page":"1604388","DOI":"10.3389\/fmed.2025.1604388","volume":"12","author":"J Hou","year":"2025","unstructured":"Hou J, Haslund-Gourley B, Diray-Arce J, Hoch A, Rouphael N, Becker PM, et al. Baseline predictors for 28-day COVID-19 severity and mortality among hospitalized patients: results from the IMPACC study. Front Med. 2025, July, 4;12:1604388. https:\/\/doi.org\/10.3389\/fmed.2025.1604388.","journal-title":"Front. Med"},{"key":"8172_CR12","doi-asserted-by":"publisher","unstructured":"Zou X, Li S, Fang M, Hu M, Bian Y, Ling J, et al. Acute physiology and chronic health evaluation II score as a predictor of hospital mortality in patients of coronavirus disease 2019. Crit Care Med. 2020, Aug;48(8):e657\u201365. https:\/\/doi.org\/10.1097\/CCM.0000000000004411.","DOI":"10.1097\/CCM.0000000000004411"},{"issue":"9","key":"8172_CR13","doi-asserted-by":"publisher","first-page":"942","DOI":"10.15252\/msb.20156297","volume":"13","author":"PE Geyer","year":"2017","unstructured":"Geyer PE, Holdt LM, Teupser D, Mann M. Revisiting biomarker discovery by plasma proteomics. Mol Syst Biol. 2017, Sept, 26;13(9):942. https:\/\/doi.org\/10.15252\/msb.20156297.","journal-title":"Mol Syst Biol"},{"issue":"5","key":"8172_CR14","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.immuni.2020.10.008","volume":"53","author":"T Shu","year":"2020","unstructured":"Shu T, Ning W, Wu D, Xu J, Han Q, Huang M, et al. Plasma proteomics identify biomarkers and pathogenesis of COVID-19. Immunity. 2020, Nov, 17;53(5):1108\u201322.e5. https:\/\/doi.org\/10.1016\/j.immuni.2020.10.008.","journal-title":"Immunity"},{"issue":"9","key":"8172_CR15","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.3390\/biom14091163","volume":"14","author":"T McLarnon","year":"2024","unstructured":"McLarnon T, McDaid D, Lynch SM, Cooper E, McLaughlin J, McGilligan VE, et al. Potential plasma proteins (LGALS9, LAMP3, PRSS8 and AGRN) as predictors of hospitalisation risk in COVID-19 patients. Biomolecules. 2024, Sept, 17;14(9):1163. https:\/\/doi.org\/10.3390\/biom14091163.","journal-title":"Biomolecules"},{"key":"8172_CR16","doi-asserted-by":"publisher","unstructured":"Bu S, Royston L, Mabanga T, Berini CA, Tremblay C, Lebouch\u00e9 B, et al. Proteomics validate circulating GDF-15 as an independent biomarker for COVID-19 severity. Front immunol. 2024 Apr 15;15:1377126. https:\/\/doi.org\/10.3389\/fimmu.2024.1377126","DOI":"10.3389\/fimmu.2024.1377126"},{"issue":"1","key":"8172_CR17","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1038\/s41467-020-17033-7","volume":"11","author":"JE Blume","year":"2020","unstructured":"Blume JE, Manning WC, Troiano G, Hornburg D, Figa M, Hesterberg L, et al. Rapid, deep and precise profiling of the plasma proteome with multi-nanoparticle protein corona. Nat Commun. 2020, July, 22;11(1):3662. https:\/\/doi.org\/10.1038\/s41467-020-17033-7.","journal-title":"Nat Commun"},{"issue":"1","key":"8172_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s13054-024-05000-3","volume":"28","author":"M Lin","year":"2024","unstructured":"Lin M, Xu F, Sun J, Song J, Shen Y, Lu S, et al. Integrative multi-omics analysis unravels the host response landscape and reveals a serum protein panel for early prognosis prediction for ARDS. Crit Care. 2024, July, 2;28(1):213. https:\/\/doi.org\/10.1186\/s13054-024-05000-3.","journal-title":"Crit Care"},{"key":"8172_CR19","doi-asserted-by":"publisher","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015, Apr, 20;43(7):e47. https:\/\/doi.org\/10.1093\/nar\/gkv007.","DOI":"10.1093\/nar\/gkv007"},{"key":"8172_CR20","unstructured":"PedregosaF, Varoquaux G, Gramfort A, Michel V, Thirion B,Grisel O, et al. Scikit-learn: Machine Learning in Python. J Mach Learn Res. 2011, Nov; 12:2825\u201330 https:\/\/dl.acm.org\/doi\/10.5555\/1953048.2078195"},{"issue":"22\u201323","key":"8172_CR21","doi-asserted-by":"publisher","first-page":"5539","DOI":"10.1093\/bioinformatics\/btaa1018","volume":"36","author":"X Lu","year":"2021","unstructured":"Lu X, Meng J, Zhou Y, Jiang L, Yan F. MOVICS: an R package for multi-omics integration and visualization in cancer subtyping. Bioinformatics. 2021, Apr;36(22\u201323):5539\u201341. https:\/\/doi.org\/10.1093\/bioinformatics\/btaa1018.","journal-title":"Bioinformatics"},{"key":"8172_CR22","doi-asserted-by":"publisher","unstructured":"Friedman JH. Greedy function approximation: a gradient boosting machine. Ann Stat. 2001 Oct 1;29(5). https:\/\/doi.org\/10.1214\/aos\/1013203451","DOI":"10.1214\/aos\/1013203451"},{"key":"8172_CR23","doi-asserted-by":"publisher","unstructured":"The gene ontology resource: 20 years and still GOing strong. Nucleic Acids Res. 2019, Jan;47(D1):D330\u20138. https:\/\/doi.org\/10.1093\/nar\/gky1055.","DOI":"10.1093\/nar\/gky1055"},{"key":"8172_CR24","doi-asserted-by":"publisher","unstructured":"Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017, Jan;45(D1):D353\u201361. https:\/\/doi.org\/10.1093\/nar\/gkw1092.","DOI":"10.1093\/nar\/gkw1092"},{"issue":"16","key":"8172_CR25","doi-asserted-by":"publisher","first-page":"8854","DOI":"10.3390\/ijms22168854","volume":"22","author":"M Szturmowicz","year":"2021","unstructured":"Szturmowicz M, Demkow U. Neutrophil extracellular traps (NETs) in severe SARS-CoV-2 lung disease. IJMS. 2021, Aug, 17;22(16):8854. https:\/\/doi.org\/10.3390\/ijms22168854.","journal-title":"IJMS"},{"issue":"12","key":"8172_CR26","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1182\/bloodadvances.2022007444","volume":"6","author":"F Puhm","year":"2022","unstructured":"Puhm F, Allaeys I, Lacasse E, Dubuc I, Galipeau Y, Zaid Y, et al. Platelet activation by SARS-CoV-2 implicates the release of active tissue factor by infected cells. Blood Adv. 2022, June, 17;6(12):3593\u2013605. https:\/\/doi.org\/10.1182\/bloodadvances.2022007444.","journal-title":"Blood Adv"},{"key":"8172_CR27","doi-asserted-by":"publisher","first-page":"667024","DOI":"10.3389\/fphys.2021.667024","volume":"12","author":"I P\u00e9rez-Torres","year":"2021","unstructured":"P\u00e9rez-Torres I, Guarner-Lans V, Soria-Castro E, Manzano-Pech L, Palacios-Chavarr\u00eda A, Valdez-V\u00e1zquez RR, et al. Alteration in the lipid profile and the desaturases activity in patients with severe pneumonia by SARS-CoV-2. Front. Physiol. 2021, May, 11;12:667024. https:\/\/doi.org\/10.3389\/fphys.2021.667024.","journal-title":"Front. Physiol"},{"key":"8172_CR28","doi-asserted-by":"publisher","unstructured":"Rothberg MB, Haessler SD. Complications of seasonal and pandemic influenza. Crit Care Med. 2010, Apr;38:e91. https:\/\/doi.org\/10.1097\/CCM.0b013e3181c92eeb.","DOI":"10.1097\/CCM.0b013e3181c92eeb"},{"key":"8172_CR29","doi-asserted-by":"publisher","first-page":"857573","DOI":"10.3389\/fimmu.2022.857573","volume":"13","author":"D Battaglini","year":"2022","unstructured":"Battaglini D, Lopes-Pacheco M, Castro-Faria-Neto HC, Pelosi P, Rocco PRM. Laboratory biomarkers for Diagnosis and prognosis in COVID-19. Front Immunol. 2022, Apr, 27;13:857573. https:\/\/doi.org\/10.3389\/fimmu.2022.857573.","journal-title":"Front. Immunol"},{"key":"8172_CR30","doi-asserted-by":"publisher","unstructured":"Jun JI, Lau LF. CCN1 is an opsonin for bacterial clearance and a direct activator of toll-like receptor signaling. Nat Commun. 2020 Mar 6;11(1):1242. https:\/\/doi.org\/10.1038\/s41467-020-15075-5","DOI":"10.1038\/s41467-020-15075-5"},{"issue":"6","key":"8172_CR31","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1096\/fj.201500173","volume":"30","author":"AR Kurundkar","year":"2016","unstructured":"Kurundkar AR, Kurundkar D, Rangarajan S, Locy ML, Zhou Y, Liu RM, et al. The matricellular protein CCN1 enhances TGF-\u03b21\/SMAD3-dependent profibrotic signaling in fibroblasts and contributes to fibrogenic responses to lung injury. FASEB J. 2016, June;30(6):2135\u201350. https:\/\/doi.org\/10.1096\/fj.201500173.","journal-title":"The FASEB J"},{"issue":"10","key":"8172_CR32","doi-asserted-by":"publisher","first-page":"111036","DOI":"10.1016\/j.isci.2024.111036","volume":"27","author":"B Liang","year":"2024","unstructured":"Liang B, Lin W, Tang Y, Li T, Chen Q, Zhang W, et al. Selenium supplementation elevated SELENBP1 to inhibit fibroblast activation in pulmonary arterial hypertension. Iscience. 2024, Sept, 26;27(10):111036. https:\/\/doi.org\/10.1016\/j.isci.2024.111036.","journal-title":"Iscience"},{"key":"8172_CR33","doi-asserted-by":"publisher","first-page":"110944","DOI":"10.1016\/j.cbi.2024.110944","volume":"393","author":"W Zhao","year":"2024","unstructured":"Zhao W, Nikolic-Paterson DJ, Li K, Li Y, Wang Y, Chen X, et al. Selenium binding protein 1 protects renal tubular epithelial cells from ferroptosis by upregulating glutathione peroxidase 4. Chemico-Biol Interact. 2024, Apr, 25;393:110944. https:\/\/doi.org\/10.1016\/j.cbi.2024.110944.","journal-title":"Chemico-Biol Interact"},{"key":"8172_CR34","doi-asserted-by":"publisher","first-page":"102807","DOI":"10.1016\/j.redox.2023.102807","volume":"65","author":"TM Philipp","year":"2023","unstructured":"Philipp TM, Gernoth L, Will A, Schwarz M, Ohse VA, Kipp AP, et al. Selenium-binding protein 1 (SELENBP1) is a copper-dependent thiol oxidase. Redox Biol. 2023, Sept;65:102807. https:\/\/doi.org\/10.1016\/j.redox.2023.102807.","journal-title":"Redox Biol"},{"issue":"6","key":"8172_CR35","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.bbalip.2018.08.017","volume":"1864","author":"E Dore","year":"2019","unstructured":"Dore E, Boilard E. Roles of secreted phospholipase A2 group IIA in inflammation and host defense. Biochim Et Biophys Acta (BBA) - Mol Cell Biol Lipids. 2019, June, 1;1864(6):789\u2013802. https:\/\/doi.org\/10.1016\/j.bbalip.2018.08.017.","journal-title":"Biochim Et Biophys Acta (BBA) - Mol Cell Biol Lipids"},{"key":"8172_CR36","doi-asserted-by":"publisher","unstructured":"Snider JM, You JK, Wang X, Snider AJ, Hallmark B, Zec MM, et al. Group IIA secreted phospholipase A2 is associated with the pathobiology leading to COVID-19 mortality. J Clin Investigation. 2021, Oct, 1;131(19):e149236. https:\/\/doi.org\/10.1172\/JCI149236.","DOI":"10.1172\/JCI149236"},{"issue":"291","key":"8172_CR37","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jconrel.2018.10.012","volume":"291","author":"R Guagliardo","year":"2018","unstructured":"Guagliardo R, P\u00e9rez-Gil J, De Smedt S, Raemdonck K. Pulmonary surfactant and drug delivery: focusing on the role of surfactant proteins. J Control Release. 2018, Dec;291(291):116\u201326. https:\/\/doi.org\/10.1016\/j.jconrel.2018.10.012.","journal-title":"J Control Release"},{"key":"8172_CR38","doi-asserted-by":"publisher","first-page":"563850","DOI":"10.3389\/fcimb.2020.563850","volume":"10","author":"KL Hartshorn","year":"2020","unstructured":"Hartshorn KL. Innate immunity and influenza a virus pathogenesis: lessons for COVID-19. Front Cell Infect Microbiol. 2020, Oct, 22;10:563850. https:\/\/doi.org\/10.3389\/fcimb.2020.563850.","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"8172_CR39","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","volume":"20","author":"MZ Tay","year":"2020","unstructured":"Tay MZ, Poh CM, R\u00e9nia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020;20(6):363\u201374. https:\/\/doi.org\/10.1038\/s41577-020-0311-8.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"8172_CR40","doi-asserted-by":"publisher","first-page":"2223057","DOI":"10.1080\/21505594.2023.2223057","volume":"14","author":"Y Liang","year":"2023","unstructured":"Liang Y. Pathogenicity and virulence of influenza. Virulence. 2023;14(1):2223057. https:\/\/doi.org\/10.1080\/21505594.2023.2223057.","journal-title":"Virulence"},{"key":"8172_CR41","doi-asserted-by":"publisher","unstructured":"Zandi M, Shafaati M, Shenagari M, Naziri H. Targeting CD47 as a therapeutic strategy: a common bridge in the therapy of COVID-19-related cancers. Heliyon. 2023, July, 4;9(7):e17959. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17959.","DOI":"10.1016\/j.heliyon.2023.e17959"},{"issue":"3","key":"8172_CR42","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/eci.12048","volume":"43","author":"E Conte","year":"2013","unstructured":"Conte E, Genovese T, Gili E, Esposito E, Iemmolo M, Fruciano M, et al. Thymosin \u03b24 protects C57BL\/6 mice from bleomycin-induced damage in the lung. Eur J Clin Investigation. 2013;43(3):309\u201315. https:\/\/doi.org\/10.1111\/eci.12048.","journal-title":"Eur J Clin Investigation"},{"issue":"12","key":"8172_CR43","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.tim.2023.07.006","volume":"31","author":"L Sarkar","year":"2023","unstructured":"Sarkar L, Liu G, Gack MU. ISG15: its roles in SARS-CoV-2 and other viral infections. Trends Microbiol. 2023, Dec;31(12):1262\u201375. https:\/\/doi.org\/10.1016\/j.tim.2023.07.006.","journal-title":"Trends Microbiol"},{"issue":"11","key":"8172_CR44","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1080\/17460441.2021.1942835","volume":"16","author":"CS Batsika","year":"2021","unstructured":"Batsika CS, Gerogiannopoulou ADD, Mantzourani C, Vasilakaki S, Kokotos G. The design and discovery of phospholipase A2 inhibitors for the treatment of inflammatory diseases. Expert Opin Drug Discov. 2021, Nov, 2;16(11):1287\u2013305. https:\/\/doi.org\/10.1080\/17460441.2021.1942835.","journal-title":"Expert Opin Drug Discov"},{"issue":"7","key":"8172_CR45","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","volume":"26","author":"A Gupta","year":"2020","unstructured":"Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020, July;26(7):1017\u201332. https:\/\/doi.org\/10.1038\/s41591-020-0968-3.","journal-title":"Nat Med"},{"issue":"11","key":"8172_CR46","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.3748\/wjg.v28.i11.1102","volume":"28","author":"D D\u2019Ardes","year":"2022","unstructured":"D\u2019Ardes D, Boccatonda A, Cocco G, Fabiani S, Rossi I, Bucci M, et al. Impaired coagulation, liver dysfunction and COVID-19: discovering an intriguing relationship. WJG. 2022, Mar, 21;28(11):1102\u201312. https:\/\/doi.org\/10.3748\/wjg.v28.i11.1102.","journal-title":"WJG"},{"issue":"6","key":"8172_CR47","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","volume":"20","author":"M Merad","year":"2020","unstructured":"Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020;20(6):355\u201362. https:\/\/doi.org\/10.1038\/s41577-020-0331-4.","journal-title":"Nat Rev Immunol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08172-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08172-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08172-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:08:16Z","timestamp":1784070496000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08172-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8172"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08172-4","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Medical Ethics Committee of Ruijin Hospital (Ruijin Hospital Ethics Committee 2024\u201358) and Shanghai General Hospital (Shanghai General Hospital Ethics Committee 2024\u2013076). Informed consent was waived by the ethics committees as the use of remnant serum samples posed no additional risks to enrolled patients. All the procedures were conducted in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"907"}}